These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10976084)

  • 1. Retinal disease in patients with systemic lupus erythematosus.
    Ushiyama O; Ushiyama K; Koarada S; Tada Y; Suzuki N; Ohta A; Oono S; Nagasawa K
    Ann Rheum Dis; 2000 Sep; 59(9):705-8. PubMed ID: 10976084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus retinopathy: a marker of active systemic lupus erythematosus.
    Seth G; Chengappa KG; Misra DP; Babu R; Belani P; Shanoj KC; Kumar G; Negi VS
    Rheumatol Int; 2018 Aug; 38(8):1495-1501. PubMed ID: 29948002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular findings in patients with systemic lupus erythematosus assessed by fundus photography with fluorescein angiography.
    Lee JH; Kim SS; Kim GT
    Clin Exp Rheumatol; 2013; 31(6):871-6. PubMed ID: 24021339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and immunological characteristics of systemic lupus erythematosus with retinopathy].
    Li M; Hou LQ; Jin YB; He J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1106-1111. PubMed ID: 36533340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe retinopathy in systemic lupus erythematosus associated with IgG anticardiolipin antibodies.
    Ravelli A; Di Fuccia G; Caporali R; Malvezzi F; Montecucco C; Martini A
    Acta Paediatr; 1993; 82(6-7):624-6. PubMed ID: 8339008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus.
    Montehermoso A; Cervera R; Font J; Ramos-Casals M; García-carrasco M; Formiga F; Callejas JL; Jorfán M; Griñó MC; Ingelmo M
    Semin Arthritis Rheum; 1999 Apr; 28(5):326-32. PubMed ID: 10342390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report of systemic lupus erythematosus patient with severe lupus retinopathy and antiphospholipid antibody].
    Imanaka H; Takei S; Hukami S; Maeno N; Shigemori M; Hokonohara M; Miyata K
    Ryumachi; 1999 Feb; 39(1):22-6. PubMed ID: 10332213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purtscher-like retinopathy in systemic lupus erythematosus.
    Wu C; Dai R; Dong F; Wang Q
    Am J Ophthalmol; 2014 Dec; 158(6):1335-1341.e1. PubMed ID: 25205559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between anti-ENO1 antibody and systemic lupus erythematosus patients with retinopathy].
    Zhang LQ; Zhao J; Wang HY; Wang ZY; Li YN; Tang JY; Li SY; Qu JF; Zhao MW
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1099-1105. PubMed ID: 36533339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of anticardiolipin antibody in patients with systemic lupus erythematosus and its association with clinical manifestations.
    Basiri Z; Gholyaf M; Faridnia M; Nadi E; Bairanvand M
    Acta Med Iran; 2013; 51(1):35-40. PubMed ID: 23456582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ocular manifestations in patients with systemic lupus erythematosus and antiphospholipid syndrome].
    Ostanek L; Modrzejewska M; Bobrowska-Snarska D; Brzosko M
    Pol Arch Med Wewn; 2007; 117 Suppl():18-23. PubMed ID: 18778014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J; Kopeć W; Jakobsche U; Prajs I; Adamiec R
    Postepy Hig Med Dosw (Online); 2007 Dec; 61():725-35. PubMed ID: 18063917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe retinal vaso-occlusive disease in systemic lupus erythematous.
    Jabs DA; Fine SL; Hochberg MC; Newman SA; Heiner GG; Stevens MB
    Arch Ophthalmol; 1986 Apr; 104(4):558-63. PubMed ID: 3954661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy.
    Giorgi D; Pace F; Giorgi A; Bonomo L; Gabrieli CB
    Hum Immunol; 1999 Aug; 60(8):688-96. PubMed ID: 10439314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristics of retinal vascular involvement in systemic lupus erythematosus].
    Ermakova NA; Alekberova ZS; Kosheleva NM; Reshetniak TN
    Vestn Oftalmol; 2001; 117(2):21-4. PubMed ID: 11510158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) levels in systemic lupus erythematosus.
    Borba EF; Santos RD; Bonfa E; Vinagre CG; Pileggi FJ; Cossermelli W; Maranhão RC
    J Rheumatol; 1994 Feb; 21(2):220-3. PubMed ID: 8182628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients.
    Yu HH; Wang LC; Lee JH; Lee CC; Yang YH; Chiang BL
    Rheumatology (Oxford); 2007 Sep; 46(9):1492-4. PubMed ID: 17673480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies.
    Borba EF; Bonfá E
    Lupus; 1997; 6(6):533-9. PubMed ID: 9256312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.